Consenso chileno sobre Abobotulinumtoxina A (Dysport®): indicaciones, técnicas

Chaná-Cuevas, Pedro; Benavides C, Olga; González H, Pilar; Aguilera A, Carlos; Arigon B, Estrella; Benavides, Olga; Canals C, María Francisca; Cueto U, Germán; Ferrada-Eguiluz, Verónica; Figueroa O, Claudia; González, Pilar; Gutiérrez P, Tania; Icarte B, Carmen; Klapp S, Cecilia; Mascayano M, Marcela; et. al.

Keywords: dystonia, spasticity, abobotulinumtoxin a, botulinum toxin type a, espasticidad, distonia, toxina botulínica tipo a

Abstract

Botulinum neurotoxin is widely used to treat a variety of movement disorders, especially dystonia and spasticity. There botúlica different preparations of botulinum type A, that because biologics are difficult to compare. AbobotulinumtoxinA (Dysport ®) has recently been introduced in Chile for treating dystonia and spasticity. The aim of this paper is to provide a review by experts on the existing evidence and propose a practical guide to the use of the drug. Methods and Results: A group of Chilean experts met on 6 and 7 July 2012 to review AbobotulinumtoxinA doses along with injection protocols for dystonia, spasticity and other movement disorders. We worked in two groups, one composed of neurologists who reviewed the on dystonias and other by physiatrists who reviewed the indications for spasticity. Conclusions: Finally, there is a proposal in terms of dose, injection points and recommendations for dystonia and spasticity.

Más información

Título según WOS: ID SCIELO:S0717-92272013000200005 Not found in local WOS DB
Título según SCIELO: Consenso chileno sobre Abobotulinumtoxina A (Dysport�): indicaciones, t�cnicas
Título de la Revista: REVISTA CHILENA DE NEUROPSIQUIATRÍA. (Rev. Chil Neuro-Psiquiat 2024; 62 (2); 177-183.)
Volumen: 51
Número: 2
Editorial: Rev. Chil Neuro-Psiquiat 2024; 62 (2); 177-183.
Fecha de publicación: 2013
Página de inicio: 115
Página final: 125
Idioma: es
URL: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-92272013000200005&lng=en&nrm=iso&tlng=en
DOI:

10.4067/S0717-92272013000200005

Notas: ISI, SCIELO